#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5042901	B	Displacement of [3H]-naloxone from mouse MOR expressed in CHO cells incubated for 1.5 hrs by competitive radioligand binding assay	Mus musculus	5		cell-based format	Scientific Literature
2.	ALA5042902	F	Agonist activity at mouse MOR expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 1 hr by scintillation counting analysis relative to DAMGO	Mus musculus	5		cell membrane format	Scientific Literature
3.	ALA5042903	F	Antagonist activity at mouse MOR expressed in CHO cells assessed as inhibition of DAMGO-induced calcium mobilization preincubated for 60 mins measured after 15 mins by calcium mobilization assay	Mus musculus	5		cell-based format	Scientific Literature
4.	ALA5042904	F	Agonist activity at mouse MOR expressed in CHO cells coexpressing Gqi5 assessed as inhibition of DAMGO-induced calcium mobilization preincubated for 60 mins measured after 15 mins by calcium mobilization assay	Mus musculus	1		cell-based format	Scientific Literature
5.	ALA5042905	B	Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay	Macaca mulatta	4		cell-based format	Scientific Literature
6.	ALA5042907	F	Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay	Homo sapiens	5		cell-based format	Scientific Literature
7.	ALA5042908	F	Agonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as stimulation of Ca2+ mobilization by calcium mobilization assay	Homo sapiens	2		cell-based format	Scientific Literature
8.	ALA5042909	B	Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis	Homo sapiens	3		cell-based format	Scientific Literature
9.	ALA5042910	T	Cytotoxicity against human GHOST CCR5 cells assessed as reduction in cell viability measured after 6 days by XTT assay	Homo sapiens	3		cell-based format	Scientific Literature
10.	ALA5042911	T	Therapeutic index, ratio of TC50 for human GHOST CCR5 cells to EC50 for inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells		2		cell-based format	Scientific Literature
11.	ALA5042912	B	Inhibition of MOR-mediated HIV1 BaL01 infection in GFP-tagged human OPRM1 transfected TZM-bl cells co-expressing HIV1 - LTR assessed as inhibition of viral entry by measuring LTR-driven luciferase activity pretreated for 1 hr before infection measured after 2 to 3 days of infection	Homo sapiens	1		cell-based format	Scientific Literature
12.	ALA5042913	B	Inhibition of MOR-mediated HIV1 BaL01 infection in GFP-tagged human OPRM1 transfected TZM-bl cells co-expressing HIV1 - LTR assessed as inhibition of viral entry in presence of morphine by measuring LTR-driven luciferase activity pretreated for 1 hr before infection measured after 2 to 3 days of infection	Homo sapiens	1		cell-based format	Scientific Literature
13.	ALA5042914	B	Inhibition of CCR5-mediated Luc-expressing HIV1 BaL Env-pseudotype virus infection in PHA-stimulated CCR5 expressing leukocytes containing human PBMC assessed as inhibition of viral entry by measuring luminescence at 100 nM pretreated for 1 hr before infection measured after 2 days of infection	Homo sapiens	1		cell-based format	Scientific Literature
14.	ALA5042915	B	Inhibition of CCR5-mediated Luc-expressing HIV1 BaL Env-pseudotype virus infection in PHA-stimulated CCR5 expressing leukocytes containing human PBMC assessed as inhibition of viral entry in presence of 10 nM morphine by measuring luminescence at 100 nM pretreated for 1 hr before infection measured after 2 days of infection	Homo sapiens	1		cell-based format	Scientific Literature
15.	ALA5042916	B	Inhibition of CCR5-mediated Luc-expressing HIV1 BaL Env-pseudotype virus infection in PHA-stimulated CCR5 expressing leukocytes containing human PBMC assessed as inhibition of viral entry in presence of 10 nM DMAGO by measuring luminescence at 100 nM pretreated for 1 hr before infection measured after 2 days of infection	Homo sapiens	1		cell-based format	Scientific Literature
16.	ALA5042917	B	Inhibition of CCR5-mediated Luc-expressing HIV1 BaL Env-pseudotype virus infection in CCR5 expressing leukocytes containing human PBMC assessed as inhibition of viral entry by measuring luminescence pretreated for 1 hr before infection measured after 2 days of infection	Homo sapiens	1		cell-based format	Scientific Literature